Why you should read this article:

•

To enhance your understanding of metastatic spinal cord compression diagnosis and management

•

To learn about a resource developed to support acute hospital staff to recognise and manage metastatic spinal cord compression

•

To be aware of the results of an audit evaluating the effects of the resource on patient care and staff adherence to guidance

Metastatic spinal cord compression (MSCC) occurs when metastatic disease causes vertebral collapse or compression of the spinal cord or when a tumour extends into the epidural space. It is an oncological emergency which will cause paralysis if left untreated. It is crucial that acute hospital staff recognise ‘red flag’ signs and symptoms of MSCC and adhere to the National Institute for Health and Care Excellence (NICE) guideline on MSCC recognition and management.

In 2019, a serious untoward incident involving a patient with confirmed MSCC was reported at an acute trust in England. This prompted the acute oncology team to examine the management of patients with MSCC at the hospital. A poster and mnemonic highlighting the main NICE recommendations were developed and distributed to all acute wards and areas. This article describes how that resource was developed and how the acute oncology team assessed its effects by conducting a two-phase retrospective and prospective audit.